Influence of Exceptional Patient Characteristics on Everolimus Exposure

NCT01948960 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: everolimus dose escalation

Sponsor

Radboud University Medical Center

Collaborators

[object Object]